Uh Oh—CRISPR Might Not Work in People – MIT Technology Review
MIT Technology Review |
Uh Oh—CRISPR Might Not Work in People
MIT Technology Review A sampling of human blood has turned up a surprise: most people could be immune to one of the world’s biggest advances in genetic engineering. It’s in our blood: Scientists searched the blood of 22 newborns and 12 adults for antibodies to the two most … |
Madison.com |
Why CRISPR Therapeutics AG Stock Is Rising Today
Madison.com CRISPR Therapeutics AG (NASDAQ: CRSP), a small-cap contender in the red hot gene-editing race, saw its shares rise by more than 19% in early morning trading today on over 10 times the average daily volume. What’s behind this eye-popping surge? Taking … Here’s What Pushed Crispr Therapeutics AG Up 23.6% in DecemberMotley Fool CRISPR Therapeutics Announces Pricing of Public Offering of Common SharesGlobeNewswire (press release) Crispr Therapeutics (CRSP) Stock: Gaining On Offering PriceCNA Finance (press release) The Ledger Gazette –Nasdaq –Post Analyst all 72 news articles » |
Madison.com |
Why CRISPR Therapeutics AG Stock Is Rising Today
Madison.com CRISPR Therapeutics AG (NASDAQ: CRSP), a small-cap contender in the red hot gene-editing race, saw its shares rise by more than 19% in early morning trading today on over 10 times the average daily volume. What’s behind this eye-popping surge? Taking … Here’s What Pushed Crispr Therapeutics AG Up 23.6% in DecemberMotley Fool CRISPR Therapeutics Announces Pricing of Public Offering of Common SharesGlobeNewswire (press release) Crispr Therapeutics (CRSP) Stock: Gaining On Offering PriceCNA Finance (press release) The Ledger Gazette –Nasdaq –Post Analyst all 72 news articles » |
Myeloma Research News |
Dual-targeted CAR T-cell Therapy Shows Promising Anti-tumor Response in Mice
Myeloma Research News CAR–T cell therapies are based on the genetic manipulation of a patient’s own T-cells. This reprogramming is designed to make the T-cells specific to certain cancer proteins, making them more efficient at eliminating tumors. For multiple myeloma … |
CNBC |
Caltech breakthrough: Bacteria engineered with ‘sonar’ can track, fight disease
CNBC New treatments like immunotherapy and probiotics can send microbe-sized fighters deep inside the body to fight illness and inflammation that has been linked to disease, but there’s a problem — they are being sent into places we can’t see … |